Tenaya Therapeutics Ownership | Who Owns Tenaya Therapeutics?


OverviewForecastFinancialsChart

Tenaya Therapeutics Ownership Summary


Tenaya Therapeutics is owned by 27.86% institutional investors, 0.56% insiders, and 71.58% retail investors. Column group is the largest institutional shareholder, holding 5.75% of TNYA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.99% of its assets in Tenaya Therapeutics shares.

TNYA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockTenaya Therapeutics27.86%0.56%71.58%
SectorHealthcare Stocks 232.01%10.74%-142.75%
IndustryBiotech Stocks 381.47%10.55%-292.02%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Column group9.40M5.75%$6.69M
Vanguard group8.56M5.24%$6.09M
Blackrock4.07M5.03%$12.63M
Empery asset management, lp5.41M3.31%$3.85B
Blackrock funding, inc. /de3.95M2.42%$2.81M
Ghost tree capital1.35M1.67%$4.18M
Renaissance1.85M1.13%$1.32M
Gsa capital partners llp1.48M0.91%$1.05M
Geode capital management1.19M0.73%$849.41K
Euclidean capital1.02M0.62%$1.65M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Column group9.40M8.08%$6.69M
Empery asset management, lp5.41M3.40%$3.85B
Ghost tree capital1.35M1.31%$4.18M
Euclidean capital1.02M0.69%$1.65M
Stepstone group lp462.16K0.35%$748.70K
Diadema partners lp315.52K0.13%$511.14K
Gsa capital partners llp1.48M0.09%$1.05M
Persistent asset partners72.49K0.08%$117.44K
Alphabet915.71K0.06%$1.48M
Mirador capital partners lp582.52K0.06%$414.47K

Top Buyers

HolderShares% AssetsChange
Empery asset management, lp5.41M3.40%5.41M
Vanguard group8.56M0.00%3.50M
Blackrock funding, inc. /de3.95M-1.62M
Gsa capital partners llp1.48M0.09%1.02M
Ghost tree capital1.35M1.31%575.00K

Top Sellers

HolderShares% AssetsChange
Ra capital management---6.98M
Woodline partners lp---5.92M
Octagon capital advisors lp---2.58M
Integral health asset management---2.38M
Vr adviser---1.56M

New Positions

HolderShares% AssetsChangeValue
Empery asset management, lp5.41M3.40%5.41M$3.85B
Schonfeld strategic advisors465.96K0.00%465.96K$754.85K
Diadema partners lp315.52K0.13%315.52K$511.14K
Xtx topco97.84K0.01%97.84K$158.50K
Persistent asset partners72.49K0.08%72.49K$117.44K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-11.00
Capital performance advisors llp-12.00
Srs capital advisors-60.00
Clearstead advisors-82.00
Rise advisors-485.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202568-27.66%45,507,06231.79%276.19%378.82%15-53.13%
Sep 30, 202591-34,496,8709.27%215.63%34-24.44%3129.17%
Jun 30, 202591-14.95%31,571,278-34.46%191.01%44-16.98%25-21.88%
Mar 31, 20252-97.70%32,748-99.92%-0.00%1-97.92%1-94.74%
Dec 31, 202449-47.31%18,984,954-67.06%220.49%29-43.14%9-47.06%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv6.48M2.99%-
US Small-Cap Growth II Equity Comp2.10M2.66%-471.71K
T. Rowe Price New Horizons2.10M2.65%-441.00
Fidelity Select Biotechnology1.75M2.20%-
JPMorgan US Small Company L785.69K0.91%-315.70K
T. Rowe Price New Horizons Tr-Z554.73K0.70%9.11K
iShares Biotechnology ETF1.45M0.67%1.45M
Vanguard Institutional Extnd Mkt Idx Tr1.11M0.51%-
Raiffeisen-Health&Wellbeing-ESG Akt A900.00K0.42%150.00K
Fidelity Small Cap Index608.02K0.37%-

Recent Insider Transactions


DateNameRoleActivityValue
Feb 25, 2026COLUMN GROUP III GP, LP-Sell$1.05M
Feb 24, 2026COLUMN GROUP III GP, LP-Sell$190.27K
Feb 24, 2026COLUMN GROUP III GP, LP-Sell$214.87K
Feb 20, 2026COLUMN GROUP III GP, LP-Sell$170.80K
Feb 23, 2026COLUMN GROUP III GP, LP-Sell$96.92K

Insider Transactions Trends


DateBuySell
2026 Q1-20
2025 Q4-3
2025 Q3-9
2025 Q2-3
2025 Q168

TNYA Ownership FAQ


Who Owns Tenaya Therapeutics?

Tenaya Therapeutics shareholders are primarily institutional investors at 27.86%, followed by 0.56% insiders and 71.58% retail investors. The average institutional ownership in Tenaya Therapeutics's industry, Biotech Stocks , is 381.47%, which Tenaya Therapeutics falls below.

Who owns the most shares of Tenaya Therapeutics?

Tenaya Therapeutics’s largest shareholders are Column group (9.4M shares, 5.75%), Vanguard group (8.56M shares, 5.24%), and Blackrock (4.07M shares, 5.03%). Together, they hold 16.03% of Tenaya Therapeutics’s total shares outstanding.

Does Blackrock own Tenaya Therapeutics?

Yes, BlackRock owns 5.03% of Tenaya Therapeutics, totaling 4.07M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 12.63M$. In the last quarter, BlackRock decreased its holdings by -627K shares, a -13.34% change.

Who is Tenaya Therapeutics’s biggest shareholder by percentage of total assets invested?

Column group is Tenaya Therapeutics’s biggest shareholder by percentage of total assets invested, with 8.08% of its assets in 9.4M Tenaya Therapeutics shares, valued at 6.69M$.

Who is the top mutual fund holder of Tenaya Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Tenaya Therapeutics shares, with 2.99% of its total shares outstanding invested in 6.48M Tenaya Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools